Matches in SemOpenAlex for { <https://semopenalex.org/work/W2574869916> ?p ?o ?g. }
- W2574869916 endingPage "e0170150" @default.
- W2574869916 startingPage "e0170150" @default.
- W2574869916 abstract "The Antibiogram properties of 1-chloro-2-isocyanatoethane derivatives of thiomorpholine (CTC), piperazine (CPC) and morpholine (CMC) were evaluated by the approved agar well diffusion, the minimum inhibitory concentration (MIC) and in silico techniques. A total of fourteen microbial cultures consisting of ten bacteria and four yeast strains were used in the biological study while affinity of the compounds for DNA gyrase, a validated antibacterial drug target, was investigated by docking method. Results indicate that both thiomorpholine and piperazine had zero activity against the Gram negative organisms tested. With morpholine, similar result was obtained except that cultures of Escherichia coli (ATCC 15442) and Salmonella typhi (ATCC 6539) presented with weak sensitivity (7-8 mm) as shown by the inhibition zone diameter (IZD) measurement. The Gram positive organisms were more sensitive to morpholine than the other compounds. The highest IZD values of 15-18 mm were achieved except for Streptococcus pneumoniae (ATCC 49619) in which mobility of the compound stopped after 12 mm. S. pneumoniae was resistant to both thiomorpholine and piperazine. The yeast strains were not sensitive to any of the studied compounds investigated. The MIC tests evaluated against a reference antibiotic show that while morpholine was most active at 4 μg.ml-1 against both B. cereus ATCC (14579) and B. subtilis, the least active compound was thiomorpholine which inhibited S. aureus (ATCC 25923) at 64 μg.ml-1. The three compounds demonstrated high affinity for the target protein (DNA gyrase) ranging from -4.63 to -5.64 Kcal/mol and even showed better ligand efficiencies than three known antibiotics; chlorobiocin, ciprofloxacin and tetracycline. This study identified the studied compounds as potential antibiotic leads with acceptable physicochemical properties and gave the molecular basis for the observed interactions between the compounds and the target protein which can be harnessed in structural optimization process." @default.
- W2574869916 created "2017-01-26" @default.
- W2574869916 creator A5027252320 @default.
- W2574869916 creator A5051487633 @default.
- W2574869916 creator A5063150507 @default.
- W2574869916 creator A5086631147 @default.
- W2574869916 date "2017-01-20" @default.
- W2574869916 modified "2023-09-25" @default.
- W2574869916 title "Experimental and In-Silico Investigation of Anti-Microbial Activity of 1-Chloro-2-Isocyanatoethane Derivatives of Thiomorpholine, Piperazine and Morpholine" @default.
- W2574869916 cites W1698681926 @default.
- W2574869916 cites W1949136023 @default.
- W2574869916 cites W1973843378 @default.
- W2574869916 cites W1981874832 @default.
- W2574869916 cites W1995288235 @default.
- W2574869916 cites W1995454965 @default.
- W2574869916 cites W2003267738 @default.
- W2574869916 cites W2003836872 @default.
- W2574869916 cites W2008212732 @default.
- W2574869916 cites W2016715372 @default.
- W2574869916 cites W2027322958 @default.
- W2574869916 cites W2031242198 @default.
- W2574869916 cites W2033495141 @default.
- W2574869916 cites W2047712305 @default.
- W2574869916 cites W2053039168 @default.
- W2574869916 cites W2058952776 @default.
- W2574869916 cites W2060268336 @default.
- W2574869916 cites W2073028672 @default.
- W2574869916 cites W2078785671 @default.
- W2574869916 cites W2085138189 @default.
- W2574869916 cites W2096052895 @default.
- W2574869916 cites W2096095251 @default.
- W2574869916 cites W2108638835 @default.
- W2574869916 cites W2118970688 @default.
- W2574869916 cites W2120083522 @default.
- W2574869916 cites W2130479394 @default.
- W2574869916 cites W2136723682 @default.
- W2574869916 cites W2147421370 @default.
- W2574869916 cites W2155448001 @default.
- W2574869916 cites W2158534713 @default.
- W2574869916 cites W2163169974 @default.
- W2574869916 cites W2165158819 @default.
- W2574869916 cites W2183288990 @default.
- W2574869916 cites W2218141880 @default.
- W2574869916 cites W2310460235 @default.
- W2574869916 cites W2401136763 @default.
- W2574869916 cites W2407040666 @default.
- W2574869916 cites W4233060568 @default.
- W2574869916 doi "https://doi.org/10.1371/journal.pone.0170150" @default.
- W2574869916 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5249067" @default.
- W2574869916 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28107379" @default.
- W2574869916 hasPublicationYear "2017" @default.
- W2574869916 type Work @default.
- W2574869916 sameAs 2574869916 @default.
- W2574869916 citedByCount "7" @default.
- W2574869916 countsByYear W25748699162018 @default.
- W2574869916 countsByYear W25748699162019 @default.
- W2574869916 countsByYear W25748699162020 @default.
- W2574869916 countsByYear W25748699162021 @default.
- W2574869916 countsByYear W25748699162022 @default.
- W2574869916 countsByYear W25748699162023 @default.
- W2574869916 crossrefType "journal-article" @default.
- W2574869916 hasAuthorship W2574869916A5027252320 @default.
- W2574869916 hasAuthorship W2574869916A5051487633 @default.
- W2574869916 hasAuthorship W2574869916A5063150507 @default.
- W2574869916 hasAuthorship W2574869916A5086631147 @default.
- W2574869916 hasBestOaLocation W25748699161 @default.
- W2574869916 hasConcept C104317684 @default.
- W2574869916 hasConcept C11636898 @default.
- W2574869916 hasConcept C167125095 @default.
- W2574869916 hasConcept C176947019 @default.
- W2574869916 hasConcept C178790620 @default.
- W2574869916 hasConcept C185592680 @default.
- W2574869916 hasConcept C2776201271 @default.
- W2574869916 hasConcept C2781056017 @default.
- W2574869916 hasConcept C501593827 @default.
- W2574869916 hasConcept C547475151 @default.
- W2574869916 hasConcept C55493867 @default.
- W2574869916 hasConcept C86803240 @default.
- W2574869916 hasConcept C89423630 @default.
- W2574869916 hasConceptScore W2574869916C104317684 @default.
- W2574869916 hasConceptScore W2574869916C11636898 @default.
- W2574869916 hasConceptScore W2574869916C167125095 @default.
- W2574869916 hasConceptScore W2574869916C176947019 @default.
- W2574869916 hasConceptScore W2574869916C178790620 @default.
- W2574869916 hasConceptScore W2574869916C185592680 @default.
- W2574869916 hasConceptScore W2574869916C2776201271 @default.
- W2574869916 hasConceptScore W2574869916C2781056017 @default.
- W2574869916 hasConceptScore W2574869916C501593827 @default.
- W2574869916 hasConceptScore W2574869916C547475151 @default.
- W2574869916 hasConceptScore W2574869916C55493867 @default.
- W2574869916 hasConceptScore W2574869916C86803240 @default.
- W2574869916 hasConceptScore W2574869916C89423630 @default.
- W2574869916 hasIssue "1" @default.
- W2574869916 hasLocation W25748699161 @default.
- W2574869916 hasLocation W25748699162 @default.
- W2574869916 hasLocation W25748699163 @default.
- W2574869916 hasLocation W25748699164 @default.
- W2574869916 hasOpenAccess W2574869916 @default.